Literature DB >> 12108550

Stage-specific antimalarial activity of cysteine protease inhibitors.

Bhaskar R Shenai1, Andrey V Semenov, Philip J Rosenthal.   

Abstract

Cysteine proteases of the malaria parasite Plasmodium falciparum, known as falcipains, are promising targets for antimalarial chemotherapy. We evaluated cultured parasites for the stage-specific expression of cysteine proteases and sensitivity to cysteine protease inhibitors. Protease activity and inhibitor sensitivity varied markedly over time. Cysteine protease activity was greatest in early trophozoites, while sensitivity to cysteine protease inhibitors was greatest in mature trophozoites. Our results indicate the importance of considering the stage-specific effects of antimalarials and are consistent with the conclusion that the principal antimalarial activity of cysteine protease inhibitors is due to a block in hemoglobin hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12108550     DOI: 10.1515/BC.2002.089

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Altered plasmodial surface anion channel activity and in vitro resistance to permeating antimalarial compounds.

Authors:  Godfrey Lisk; Margaret Pain; Morgan Sellers; Philip A Gurnev; Ajay D Pillai; Sergey M Bezrukov; Sanjay A Desai
Journal:  Biochim Biophys Acta       Date:  2010-05-06

2.  Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Authors:  Puran S Sijwali; Kentaro Kato; Karl B Seydel; Jiri Gut; Julie Lehman; Michael Klemba; Daniel E Goldberg; Louis H Miller; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

3.  Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.

Authors:  S Eksi; B Czesny; G-J van Gemert; R W Sauerwein; W Eling; K C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

4.  Improved prediction of malaria degradomes by supervised learning with SVM and profile kernel.

Authors:  Rui Kuang; Jianying Gu; Hong Cai; Yufeng Wang
Journal:  Genetica       Date:  2008-12-06       Impact factor: 1.082

5.  Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.

Authors:  Ebere Sonoiki; Andres Palencia; Denghui Guo; Vida Ahyong; Chen Dong; Xianfeng Li; Vincent S Hernandez; Yong-Kang Zhang; Wai Choi; Jiri Gut; Jennifer Legac; Roland Cooper; M R K Alley; Yvonne R Freund; Joseph DeRisi; Stephen Cusack; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development.

Authors:  Ying Pei; Jessica L Miller; Scott E Lindner; Ashley M Vaughan; Motomi Torii; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

7.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Authors:  Puran S Sijwali; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax.

Authors:  Byoung-Kuk Na; Bhaskar R Shenai; Puran S Sijwali; Youngchool Choe; Kailash C Pandey; Ajay Singh; Charles S Craik; Philip J Rosenthal
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

9.  A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.

Authors:  Ebere Sonoiki; Caroline L Ng; Marcus C S Lee; Denghui Guo; Yong-Kang Zhang; Yasheen Zhou; M R K Alley; Vida Ahyong; Laura M Sanz; Maria Jose Lafuente-Monasterio; Chen Dong; Patrick G Schupp; Jiri Gut; Jenny Legac; Roland A Cooper; Francisco-Javier Gamo; Joseph DeRisi; Yvonne R Freund; David A Fidock; Philip J Rosenthal
Journal:  Nat Commun       Date:  2017-03-06       Impact factor: 14.919

10.  Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.

Authors:  Kirthana M V Sindhe; Wesley Wu; Jenny Legac; Yong-Kang Zhang; Eric E Easom; Roland A Cooper; Jacob J Plattner; Yvonne R Freund; Joseph L DeRisi; Philip J Rosenthal
Journal:  mBio       Date:  2020-01-28       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.